Cited by 86Virus-based gene therapy researchRetinal Development and DisordersRNA Interference and Gene Delivery

Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting

Open access
Carvalho, Livia S., Turunen, Heikki T., Wassmer, Sarah J., Luna-Velez, María V., Xiao, Ru, Bennett, Jean, Vandenberghe, Luk H.·2017·Frontiers in Neuroscience

Abstract

Retinal gene therapy has come a long way in the last few decades and the development and improvement of new gene delivery technologies has been exponential. The recent promising results from the first clinical trials for inherited retinal degeneration due to mutations in RPE65 have provided a major breakthrough in the field and have helped cement the use of recombinant adeno-associated viruses (AAV) as the major tool for retinal gene supplementation. One of the key problems of AAV however, is its limited capacity for packaging genomic information to a maximum of around 4.8 kb. Previous studies have demonstrated that homologous recombination and/or inverted terminal repeat (ITR) mediated concatemerization of two overlapping AAV vectors can partially overcome the size limitation and help deliver larger transgenes. The aim of this study was to investigate and compare the use of different AAV dual-vector approaches in the mouse retina using a systematic approach comparing efficiencies in vitro and in vivo using a unique oversized reporter construct. We show that the hybrid approach relying on vector genome concatemerization by highly recombinogenic sequences and ITRs sequence overlap offers the best levels of reconstitution both in vitro and in vivo compared to trans-splicing and overlap strategies. Our data also demonstrate that dose and vector serotype do not affect reconstitution efficiency but a discrepancy between mRNA and protein expression data suggests a bottleneck affecting translation.

AI snapshot

Written from the paper’s full text.

TL;DR

This study systematically compared dual AAV vector strategies (trans-splicing, overlapping, hybrid) for delivering an oversized lacZ reporter to HEK293 cells and mouse retina. The hybrid strategy gave the highest in vivo reconstitution (~9% of control), but reconstitution was low overall and mRNA levels (~60%) far exceeded protein levels (~10%), suggesting a translation bottleneck.

Key findings

  • In vitro, dual-vector β-galactosidase reconstitution efficiencies were 10.3% (trans-splicing, TS), 15.3% (hybrid, HB), and 17.4% (overlap, OL) of CMV.lacZ control; OL was numerically highest in this assay.
  • In vivo in mouse retina, HB reconstitution was 9.07% of control, TS was 1.78%, and OL was below assay background (−0.67% ± SEM 0.54); HB was therefore the most efficient in vivo.
  • Serotype did not change HB reconstitution: AAV8 gave 9.07% and Anc80L65 gave 9.57%, despite the Anc80L65 CMV.lacZ control being 14-fold higher than AAV8.
  • Dose effects: in vitro HB efficiency rose from 8.4% to 15.1% to 17.7% at MOI 1E7, 1E8, and 1E9; in vivo a 5-fold dose increase produced only 2.2-fold mRNA and 1.5-fold protein increases, and mRNA suggested ~60% reconstitution versus ~10% by protein.

Methods

  • An oversized Rainbow reporter (mCherry, lacZ, Gluc, and eGFP separated by furin-2A cleavage sites) was split within lacZ into left and right vectors; dual strategies were OL, TS, and HB, with CMV.lacZ as control.
  • In vitro: HEK293 cells were transduced with AAV2/2 dual vectors at defined MOIs, and β-galactosidase was quantified after 48 h. In vivo: C57BL/6J-Tyrc-2J/J male mice (6–8 weeks) received subretinal injections of AAV2/8 or Anc80L65 dual vectors at low dose 3E9 vg/eye or high dose 1.5E10 vg/eye; 4–6 eyes per group; retinas were collected 4 weeks post-injection.
  • β-galactosidase activity was normalized to CMV.lacZ controls and corrected for plasmid reconstitution rates; lacZ mRNA was measured by qPCR using the ΔCT method with GAPDH as reference; two-tail Student’s t-test was used with significance at p < 0.01.

Limitations

  • Stated: dual AAV reconstitution remains low and the cellular mechanisms are poorly understood; mRNA and protein levels may be inherently flawed indicators of reconstitution without identical-sequence controls; oversized monocistronic controls cannot be used; OL efficiency is gene- and sequence-dependent; in vivo work used subretinal injection only, not intravitreal delivery.
  • Stated: HB reconstitution may be sensitive to minor sequence or ITR variations, and the intein-based alternative has not been thoroughly characterized.
  • Evident from the text: findings come from one oversized reporter in HEK293 cells and mouse retina, with 4–6 eyes per group and 1–2 in vitro assays in triplicate; no human data are reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fnins.2017.00503

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

19 of 28 cited sources checked · 10 supported · 1 flagged · accuracy not yet measured

  • Premisecitation

    Due to lack of proper controls and accurate protein quantification methods, determining parameters for clinical approaches has been lacking.

    “Even though vector reconstitution in the retina has been detected for clinically relevant large transgenes, such as ABCA4 or MYO7A, due to lack of proper controls (e.g., using oversized monocistronic vectors) and accurate protein quantification methods, determining parameters for clinical approaches has been lacking (Dyka et al., 2014; Trapani et al., 2014, 2015).”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites Dyka et al., 2014 source

      The Discussion (page unavailable) says that the amount of protein required for therapy remains an important question, supporting the claim that clinical parameters were not yet established. But the Results section on retinal expression (page unavailable) reports using an oversized single fAAV-MYO7A vector for comparison, contrary to the claimed lack of that control. The Methods and Results also describe semiquantitative protein measurements, though they do not establish accurate quantification of retinal protein levels. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites Trapani et al., 2014 source

      The Results (pages not specified in our copy) report comparisons with oversized AAV vectors and quantification of ABCA4 and MYO7A expression, contrary to the attributed lack of controls and protein quantification. The paper also reports testing vector doses and ratios and selecting an optimal regimen for subsequent experiments; it does not identify those alleged deficiencies as the reason clinical parameters were lacking. (LLM, conf=0.87)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites Trapani et al., 2015 source

      The Materials and Methods (Western blot analysis; page unavailable) describe relative ABCA4 protein quantification using control lanes. The Discussion (page unavailable) reports variable expression and therapeutic effects, but neither passage says that missing oversized-vector controls or inadequate protein quantification prevented clinical parameters from being determined. Searches for those controls and for clinical parameter thresholds did not establish the claimed causal explanation. (LLM, conf=0.72)

      Experimental — accuracy not yet measured
  • Premisecitation

    Vectors carrying larger genomes have lower transduction capacity, most likely due to preferential degradation of vectors encapsidating larger genomes.

    “It has also been shown that vectors carrying larger genomes have lower transduction capacity, most likely due to a preferential degradation of vectors encapsidating larger genomes (Grieger and Samulski, 2005).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Grieger and Samulski, 2005 source
  • Premisecitation

    AAV has a shortcoming of limited genetic payload capacity.

    “However, despite its safety and efficacy as a gene therapy vector, AAV has its shortcomings, one being the limited capacity of its genetic payload (Kotterman and Schaffer, 2014).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Kotterman and Schaffer, 2014 source
  • Findingown data

    The OL construct containing the largest homology sequence generated the best reconstitution efficiency.

    “The construct containing the largest homology sequence generated the best reconstitution efficiency therefore was used hereafter (data not shown).”
    Quote in the paperSubstantial claim
  • Findingown data

    The hybrid approach offers the best levels of reconstitution both in vitro and in vivo compared to trans-splicing and overlap strategies.

    “We show that the hybrid approach relying on vector genome concatemerization by highly recombinogenic sequences and ITRs sequence overlap offers the best levels of reconstitution both in vitro and in vivo compared to trans-splicing and overlap strategies.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 23
  • May combine two claims. 23
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The three dual approaches have been used to express MYO7A and ABCA4 genes and showed effective in vitro protein expression.

    “Furthermore, the three dual approaches (trans-splicing, overlapping or “hybrid” techniques) have been used to express the MYO7A and the ABCA4 genes (both with CDS over 6 kb in length and expressed in the retina) and showed effective in vitro protein expression (Dyka et al., 2014).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Dyka et al., 2014 source

      The Results section (page not provided) reports full-length MYO7A protein expression in HEK293 cells using the dual-vector approaches. The Discussion mentions in vitro ABCA4 expression, but says the simple-overlap approach was highly inefficient relative to other platforms; it does not establish effective expression of ABCA4 with all three approaches. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    The difference between OL reconstitution in RPE cells and photoreceptors may be due to differences in overlap lengths and sequences.

    “Even though others have detected OL reconstitution in RPE cells, but not photoreceptors, this may be due to differences in overlap lengths and sequences (Trapani et al., 2015).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Trapani et al., 2015 source

      The Results section on recombinogenic regions (page unavailable) compares different homology sequences and reports differences in how frequently they yield ABCA4 expression in mouse photoreceptors. It also notes lower recombination-based vector efficiency in photoreceptors than in cell culture. It does not compare overlapping-vector reconstitution in RPE cells and photoreceptors or attribute such a difference to overlap length and sequence. (LLM, conf=0.77)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Both transcription and translation are strongly affected by exact DNA and mRNA sequences, respectively, as well as their cellular environments.

    “Both transcription and translation are strongly affected by exact DNA and mRNA sequences, respectively, as well as their cellular environments (Sonenberg and Hinnebusch, 2009; Alpert et al., 2017).”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Sonenberg and Hinnebusch, 2009 source

      The Introduction (page not available in our copy) explains that mRNA sequences and structures affect translation initiation, while cellular conditions such as starvation or stress can alter translation. It does not establish the corresponding claim that DNA sequence and cellular environment affect transcription. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites Alpert et al., 2017 source

      The Abstract states that DNA sequence, gene architecture, and chromatin regulate transcription elongation rates; the Introduction also discusses cell signaling and environmental cues as possible constraints. The paper does not address whether mRNA sequence or cellular environment strongly affects translation, so it supports the transcription part but not the full sentence attributed to it. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Others have detected OL reconstitution in RPE cells, but not photoreceptors.

    “Even though others have detected OL reconstitution in RPE cells, but not photoreceptors, this may be due to differences in overlap lengths and sequences (Trapani et al., 2015).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Trapani et al., 2015 source

      The Results section reports photoreceptor expression from dual AAV hybrid vectors, while its RPE measurements concern lipofuscin. I searched for overlapping-vector (OL) reconstitution in RPE cells but not photoreceptors; the retrieved passages do not report that comparison. No page number was supplied for these passages. (LLM, conf=0.70)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    AAV8 and Anc80L65 both transduce retinal cells with high efficiencies.

    “Effect of serotype on vector reconstitution was studied by comparing AAV8 and Anc80L65, both of which transduce retinal cells with high efficiencies (Zinn et al., 2015).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Zinn et al., 2015 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Vector reconstitution has been reported in vitro in several cell lines, and in vivo in mouse liver, skeletal muscle, and retina.

    “Vector reconstitution has been reported in vitro in several cell lines, and in vivo in mouse liver, skeletal muscle, and retina (Grieger and Samulski, 2005).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Grieger and Samulski, 2005 source

      The introductory passage labelled Abstract describes split-vector systems that rely on recombination of two vector genomes within a cell, supporting the general idea of vector reconstitution. It does not report reconstitution in several cell lines or in mouse liver, skeletal muscle, or retina. The Results describe transduction of cultured cells, not those specific reconstitution findings; page numbers are unavailable in our copy. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Different relative efficiencies of dual AAV vectors have been reported by others, especially regarding HB and TS.

    “Interestingly, different relative efficiencies have been reported by others, especially regarding HB and TS (Dyka et al., 2014; Trapani et al., 2014).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Dyka et al., 2014 source
    • cites Trapani et al., 2014 source
  • Classified as probably not a substantial claim.

    Premisecitation

    Vector reconstitution in the retina has been detected for clinically relevant large transgenes, such as ABCA4 or MYO7A.

    “Even though vector reconstitution in the retina has been detected for clinically relevant large transgenes, such as ABCA4 or MYO7A, due to lack of proper controls (e.g., using oversized monocistronic vectors) and accurate protein quantification methods, determining parameters for clinical approaches has been lacking (Dyka et al., 2014; Trapani et al., 2014, 2015).”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites Dyka et al., 2014 source
    • cites Trapani et al., 2014 source
    • cites Trapani et al., 2015 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    An alternate method for expressing large proteins relying on intein protein sequences has been reported.

    “An alternate method for expressing large proteins relying on intein protein sequences has also been reported (Li et al., 2008; Truong et al., 2015; Chew et al., 2016).”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites Li et al., 2008

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Truong et al., 2015 source
    • cites Chew et al., 2016 source
  • May combine two claims.

    Findingown data

    In vitro, dual vector dose increases of 10-fold and 100-fold resulted in 17-fold and 102-fold increases in reporter transgene expression, respectively.

    “We also studied whether the effect of dose of dual vector transduction correlates linearly with reporter transgene expression in vitro, and detected 17 and 102-fold increases in expression when dual vector dose was increased 10 and 100-fold to controls, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In vitro, reconstitution efficiencies based on protein expression normalized to controls were 15.3% for HB, 17.4% for OL, and 10.3% for TS.

    “When reconstitution efficiencies based on protein expression were quantified by normalizing lacZ expression levels to their respective controls, levels of 15.3, 17.4, and 10.3% were detected for HB, OL and TS, respectively.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Functionality of dual vectors and controls was assessed in vitro, and protein expression from oversized reporter was similar to normal sized controls.

    “Functionality of our dual vectors and controls was assessed in vitro, and showed that protein expression from oversized reporter was similar to normal sized controls.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In vivo in mouse retina, dual vector reconstitution efficiencies were 9.07% of control for HB and 1.78% for TS.

    “Reconstitution efficiencies were 9.07 and 1.78% of control for HB and TS, respectively (Figure 3A).”
    • Also stated in: § Discussion · hedged
      “Our data indicates different relative efficiencies of reconstitution in vivo in mouse retina with levels compared to control, of 9.07% for HB, 1.78% for TS, and below detection for OL.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In vivo, reconstitution efficiency was assessed to be ~10% based on protein activity, while mRNA amounts suggested ~60% efficiency.

    “While reconstitution efficiency was assessed to be ~10% based on protein activity, mRNA amounts suggested ~60% efficiency.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    Each dual AAV approach will result in reconstitution of transcriptionally active Rainbow construct.

    “Each approach will result in reconstitution of transcriptionally active Rainbow construct.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    The rate of rAAV genome reconstitution may be quantifiable, but resulting mRNA or protein levels are not, unless controls of identical sequences are used.

    “Rate of rAAV genome reconstitution may be quantifiable, but resulting mRNA or protein levels are not, unless controls of identical sequences are used.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Transfection experiments were done in triplicates with identical conditions to ensure equal transfection efficiencies.

    “Transfection experiments were done in triplicates with identical conditions to ensure equal transfection efficiencies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Study design and conductnone given

    The lacZ primer/probe assay was specifically designed to span the exact location where the lacZ gene is split into left and right constructs in the dual hybrid strategy.

    “The lacZ primer/probe assay was specifically designed to span the exact location where the lacZ gene is split into left and right constructs in the dual hybrid strategy.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given

    The drastic decrease in OL efficiency in vivo may reflect differences in activities of pathways responsible for homologous recombination in vivo as compared to in vitro.

    “The drastic decrease in OL efficiency may reflect differences in activities of pathways responsible of homologous recombination in vivo as compared to in vitro.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Packaged AAV genomes never exceeded 5.2 kb in length, but overpackaging results in genome fragmentation.

    “A study by Wu et al. (2010) showed that packaged AAV genomes never exceeded 5.2 kb in length, but overpackaging results in genome fragmentation.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Wu et al., 2010

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationown data

    The TS approach has several different ways that the left and right vectors could come together, which overall lowers the probability of correct concatamerization and consequently reconstitution efficiency.

    “As we show in Figure 1E, there are several different ways that the left and right vectors from the TS approach could come together, which overall lowers the probability of correct concatamerization and consequently reconstitution efficiency.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductreasoning

    Correct reconstitution can be accurately quantified by measuring β-galactosidase with standard enzymatic assays because neither left nor right constructs contains a full lacZ coding sequence.

    “As neither left nor right constructs contains a full lacZ coding sequence, correct reconstitution can be accurately quantified by measuring the amount of its protein product, β-galactosidase, with standard enzymatic assays.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Dual AAV approaches can partially overcome the size limitation and deliver larger transgenes.

    “Previous studies have demonstrated that homologous recombination and/or inverted terminal repeat (ITR) mediated concatemerization of two overlapping AAV vectors can partially overcome the size limitation and help deliver larger transgenes.”
    • Also stated in: § Introduction · plain
      “It has been shown that the fragments will reassemble when transferred to a cell and produce a full-length protein (Yan et al., 2000, 2002; Duan et al., 2003; Hirsch et al., 2009).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Yan et al., 2000, 2002; Duan et al., 2003; Hirsch et al., 2009

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning

    Reconstitution based on uniform homologous sequences, such as in the hybrid approach, should result in equal efficiencies regardless of the transgene.

    “In contrast, reconstitution based on uniform homologous sequences, such as in the hybrid approach, should result in equal efficiencies regardless of the transgene.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In the retina, the dual approach was first reported by Reich et al. (2003) using trans-splicing to show β-galactosidase expression in vivo around 40% after AAV5 subretinal injection.

    “In the retina, the dual approach was first reported by Reich et al. (2003) which used the trans-splice technique to show that β-galactosidase expression in vivo was around 40% after AAV5 subretinal injection (Reich et al., 2003).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Reich et al., 2003 source
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationnone given

    Original Rainbow sequence is anticipated to be restored only after OL reconstitution, whereas TS will have an intron containing an AAV ITR sequence, and HB will have an intron with AP or AP-ITR-AP sequence.

    “Original Rainbow sequence is anticipated to be restored only after OL reconstitution, whereas TS will have an intron containing an AAV ITR sequence, and HB will have an intron with AP or AP-ITR-AP sequence (Figures 1D,E).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All animal procedures were performed in accordance with protocols approved by institutional animal care and use committees at SERI and conformed to ARVO guidelines.

    “All animal procedures were performed in accordance with protocols approved by the institutional animal care and use committees at SERI and conformed to the guidelines on the care and use of animals adopted by the Association for Research in Vision and Ophthalmology (Rockville, MD).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationcitation

    The drastic differences in HB reconstitution within AP intron sequence seen between different studies may reflect undetected or unreported mutations between sequences, especially in the ITRs, indicating sensitivity of reconstitution to minor variations.

    “While all designs seemingly use sequences originally reported by Ghosh et al. (2008), the drastic differences in HB reconstitution within AP intron sequence seen between the different studies, may reflect undetected or unreported mutations between sequences, especially in the ITRs, indicating sensitivity of reconstitution to minor variations (Ghosh et al., 2008).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ghosh et al., 2008 source
  • May combine two claims.

    Interpretationreasoning

    Regulatory sequences required to drive gene expression add to the final size and may render many genes too large for AAV packaging.

    “Moreover, regulatory sequences that may be required to drive gene expression add to the final size and may render many genes too large for AAV packaging.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationnone given

    For clinical purposes, dual AAV approaches may be feasible if sufficient protein expression levels to affect the disease phenotype can be achieved, regardless of the de facto efficiency of the reconstitution process.

    “For clinical purposes, dual AAV approaches may be feasible if sufficient protein expression levels to affect the disease phenotype can be achieved, regardless of the de facto efficiency of the reconstitution process.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Interpretationnone given

    OL reconstitution depends on the recombinogenic capacity of the sequence, which is expected to be gene-dependent.

    “and on the recombinogenic capacity of this sequence, which is expected to be gene-dependent.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductreasoning

    An enzymatic assay identifies reconstitution based on protein function, not just size, thus excluding potential incorrect reconstitution events.

    “Further, an enzymatic assay identifies reconstitution based on protein function, not just size, thus excluding potential incorrect reconstitution events.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In the intein approach, the transgene is divided into two parts, with the 5′ half expressing a C-terminal intein sequence and the 3′ half an N-terminal intein sequence.

    “In this approach, the transgene is divided into two parts in which 5′ half of the gene will express a C-terminal intein sequence, and 3′ half an N-terminal intein sequence.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    As of now, dual AAV vector strategies may be of use in gene therapy modalities where even limited transgene expression has positive effects on disease phenotype.

    “As of now, dual AAV vector strategies may be of use in gene therapy modalities where even limited transgene expression has positive effects on disease phenotype.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.

    Interpretationreasoning

    Inteins are of bacterial origin and may be immunogenic.

    “Finally, inteins are of bacterial origin, and as such may be immunogenic.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    In the intein approach, both vector halves need separate transcriptional regulators, and the added length of intein sequences diminishes gain of payload carrying capacity compared to genome reconstitution approaches.

    “Also, as the two peptides need to be expressed, both vector halves will need their separate transcriptional regulators, and with the added length of the intein sequences, gain of payload carrying capacity is diminished as compared to genome reconstitution approaches.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisereasoning

    Reconstitution in the intein approach takes place on peptide level in a process termed protein splicing, where the intein sequences excise themselves and join the remaining peptides together.

    “Reconstitution will therefore take place on peptide level in a process termed protein splicing, where the intein sequences excise themselves and join the remaining peptides together.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given

    Proteins can be split by inteins only at certain sites, and the reconstituted protein may not reach proper conformation due to the two peptides folding separately.

    “Further, proteins can be split by inteins only at certain sites, and the reconstituted protein may not reach proper conformation due to the two peptides folding separately.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Co-transduction can also be achieved by intravitreal injection, which targets the retinal ganglion cells and inner retina, albeit at much lower efficiencies than by subretinal injections.

    “However, co-transduction can also be achieved by intravitreal injection, which targets the retinal ganglion cells and inner retina (Hung et al., 2016), albeit at much lower efficiencies than by subretinal injections.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Hung et al., 2016 source
39 of 39
  • The paper relies on this without support.

    A more fundamental understanding of vector reconstitution efficiencies has been lacking.

    “Even though the dual AAV method feasibility has been demonstrated by rescue of disease phenotype in different models, a more fundamental understanding of vector reconstitution efficiencies has been lacking.”
  • The paper relies on this without support.

    The low efficiency of AAV dual strategies remains a hurdle for further ocular translational applications, even when using vectors with extremely high retinal transduction capacity like AAV8.

    “Furthermore, despite promising results, the low efficiency of AAV dual strategies remains a hurdle for further ocular translational applications, even when using vectors with extremely high retinal transduction capacity like AAV8.”
  • The paper relies on this without support.

    The dual AAV method feasibility has been demonstrated by rescue of disease phenotype in different models.

    “Even though the dual AAV method feasibility has been demonstrated by rescue of disease phenotype in different models, a more fundamental understanding of vector reconstitution efficiencies has been lacking.”
  • The paper relies on this without support.

    Several important candidate genes for gene replacement therapies, such as USH2A, F8 or DMD, are too large for AAV.

    “several important candidate genes for gene replacement therapies, such as USH2A (Usher syndrome type 2A), F8 (hemophilia A) or DMD (Duchenne muscular dystrophy), are too large.”
  • The paper relies on this without support.

    Dual AAV vector strategies rely on rAAV genome concatamerization utilizing ITRs and/or transgene cassette sequence homologies.

    “Dual AAV vector strategies rely on rAAV genome concatamerization utilizing ITRs and/or transgene cassette sequence homologies.”
  • The paper relies on this without support.

    In vivo efficiencies of dual AAV vectors of ~5–10% compared to single AAV approaches have been reported.

    “Depending on experimental details, in vivo efficiencies of ~5–10% as compared to transgene expression from single AAV approaches have been reported”
  • The paper relies on this without support.

    In some model systems, dual AAV vector reconstitution has resulted in rescue of a disease phenotype.

    “and in some model systems this has resulted in rescue of a disease phenotype”
  • The paper relies on this without support.

    Studies comprehensively comparing efficiencies of different dual AAV vector strategies in the retina have been limited.

    “Studies comprehensively comparing efficiencies of different dual AAV vector strategies in the retina have been limited.”
  • The paper relies on this without support.

    Proof of concept studies have shown feasibility of the intein approach, but its efficiency has never been thoroughly characterized.

    “Even though proof of concept studies have shown feasibility of this approach, its efficiency has never been thoroughly characterized.”
  • The paper relies on this without support.

    Details behind cellular mechanisms underlying vector reconstitution are still poorly understood.

    “However, even though dual AAV vector strategies have been shown to work, details behind cellular mechanisms underlying vector reconstitution are still poorly understood.”
10 of 10

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The hybrid dual AAV strategy was initially proposed by Gosh and colleagues in 2008 and found to significantly improve transgene reassembly in a variety of studies thereafter.

    “The hybrid dual AAV strategy was initially proposed by Gosh and colleagues in 2008 [54] and found to significantly improve transgene reassembly in a variety of studies thereafter [29,49].”

    From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [49]

    The Abstract and Discussion report that the hybrid approach gave the best reconstitution in vivo in mouse retina, and the Introduction says multiple studies found hybrid and trans-splicing among the most efficient dual-AAV approaches. But the Results report higher in-vitro reconstitution for the overlap approach than for hybrid, so this paper does not establish a consistent, significant improvement across a variety of studies. The separate attribution of the strategy’s 2008 origin is attached to a different citation. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Overlapping vectors were not as successful in terminally differentiated photoreceptors, suggesting some targets may be intrinsically more refractory to this approach.

    “Contrarily, overlapping vectors were not as successful in terminally differentiated photoreceptors [29,49], suggesting that some targets may be intrinsically more refractory to this approach.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Hybrid is called best in vitro despite higher overlap efficiency

    Major

    The abstract says the hybrid approach performed best in vitro, but the reported in vitro reconstitution efficiency was 17.4% for overlap versus 15.3% for hybrid.

  • High-dose group received tenfold, not fivefold, the total viral genomes

    Minor

    The high-dose group received 1.5E10 vg/eye of each of two constructs, or 3E10 vg/eye total. That is ten times the low-dose group's stated total of 3E9 vg/eye, not five times.

2 of 2

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carvalho, L. S., Turunen, H. T., Wassmer, S. J., Luna-Velez, M. V., Xiao, R., Bennett, J., & Vandenberghe, L. H.
Affiliations
  • Massachusetts Eye and Ear Infirmary (US)
  • University of Pennsylvania (US)
Corresponding author
Vandenberghe, Luk H.
Venue
Frontiers in Neuroscience
Published
2017-09-08
Volume
11
Pages
503-503
ISSN
1662-453X (ISSN-L)
OpenAlex
W2746153430
Cited by
86
References
31
Citations by year
2026: 4 · 2025: 12 · 2024: 7 · 2023: 14 · 2022: 11 · 2021: 10 · 2020: 17 · 2019: 8 · 2018: 3
FWCI
5.08
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • Grousbeck Family Foundation
  • Foundation Fighting Blindness (TA-GT -0611 -0571 -SCHMEE-WG)
  • National Institutes of Health (5DP1EY023177)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
retinal gene therapy, recombinant adeno-associated virus, inverted terminal repeats, homologous recombination, trans-splicing, RPE65, inherited retinal degeneration, mouse retina

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-28.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-28.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review